Hypertrophic Cardiomyopathy for Professionals
Learning more about HCM will ensure you are better able to discuss its impact with your patients.
Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder defined by left ventricular (LV) hypertrophy that cannot be explained by another cardiac or systemic disease.
HCM Clinical Review
Learn more on recognizing and evaluating the pathophysiology of hypertrophic cardiomyopathy (HCM) with AHA’s Hypertrophic Cardiomyopathy Clinical Review.
HeartBEATS from Lifelong Learning™
Educating Patients and Their Caregivers About HCM
Living with Arrhythmic Consequences of HCM
This episode will highlight factors to consider when deciding on ICD placement, particularly for primary prevention of sudden cardiac death.
Claim CE and MOC Credit
HCM: Identifying Symptoms
Learn tips and tricks for the initial diagnosis of HCM, diagnostic testing, and referrals.
Claim CE and MOC Credit
HCM: Managing Symptoms
Lean more on identifying strategies to improve provider-patient communication and utilizing shared decision-making to personalize treatment strategies.
Claim CE and MOC Credit
HCM: Lifestyle Interventions
Experts will cover behavior modifications for patient with HCM, including regular physical activity recommendations.
Claim CE and MOC Credit
AHA Lifelong Learning and HCMA developed tools and resources to educate patients and caregivers during the HCM patient journey.
Cardiac MRI
Echocardiograms
Stress Echocardiogram
Download our printable information sheet:
Videos on Demand
Watch these Videos on Demand when it is most convenient for you.
-
AHA HCM Clinical Update: 2024 Guideline for Management of HCM
Watch now to enhance your knowledge on the importance of shared decision-making, the use of cardiac myosin inhibitors to treat symptomatic obstructive HCM, and risk stratification for atrial fibrillation to improve patient outcomes.
-
Putting a Clinical Spotlight on HCM with Case Studies
In this series of lightning talks, seven leading experts will tackle case studies and explore the complexities of HCM diagnosis, management, and treatment. Each case study will highlight aspects of the varied HCM patient journey and pursuit of accurate diagnosis.
How much do you know about HCM?
Hypertrophic cardiomyopathy affects up to 1.5 million Americans. Test your knowledge on diagnosing and treating HCM.
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
EmailResults
Results:
You scored: {{ formCtrl.response.Summary.TotalScore }}
12 – 20 Points:
Review the ACC/AHA Hypertrophic Cardiomyopathy guidelines and try one of our HCM Webinars or Podcasts to learn more.
Your Summary
-
Question{{item.Question}}Your Answers•{{answer}}{{item.Tip}}
|
|
Your Summary
|
|
{{++index}}. {{item.Question}}
|
HCM Patients
In speaking with patients who complain of symptoms consistent with HCM, ask if family members have been diagnosed with HCM, or if there is a family history of sudden cardiac arrest or died due to an unknown cardiovascular disease. When patients present with symptoms such as fatigue, fainting, shortness of breath, chest pain or heart palpitations without a known cause, suspect and test for HCM. With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities.
Download this free poster developed in collaboration with HCMA
Print this poster as a discussion guide for conversations with patients. As you talk with your patients use this as an educational tool. Early detection and disease/symptom management may help reduce some of the consequences of HCM and improve outcomes.
With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities.
HCM - Sudden Cardiac Death Risk Calculator
This calculator is for use in calculating risk of sudden cardiac death in patients with HCM using the 2020 AHA/ACC Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy.
Risk for Atrial Fibrillation in HCM
The HCM-AF Risk Calculator score provides patients, who have an HCM diagnosis, with individualized estimates of their risk for developing new-onset atrial fibrillation in the two-year and five-year periods following their evaluation.
HCM Roundtable Report
Recognizing the importance of confronting HCM and the broad range of individuals working on various aspects of the disease, the AHA has hosted roundtable discussions. This report identifies steps needed to achieve an "ideal state" for HCM patients.
Guidelines and Articles
- 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines | Circulation (ahajournals.org)
- 2024 Clinical Update Slide Set (PDF)
- Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives Evidence for a Change in Paradigm. Circulation, June 2020.
- Cardiomyopathy in Children: Classification and Diagnosis. Circulation, June 2020.
- Maron BJ. Hypertrophic Cardiomyopathy. Circulation. 2002;106:2419-2421.
News
- 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy AHA Science News
- Deadly heart problem might not be so deadly AHA News, 2019.
- Genetic testing helps family uncover inherited heart condition AHA News, 2019.
American Heart Association Professional Members
Enjoy instant benefits!
- Free Online Access to AHA Scientific Journals
- Affiliate with our 16 Scientific Councils
- Discounts on Scientific Conference Registration and Online Courses
